Endocannabinoids limit excessive mast cell maturation and activation in human skin.

[1]  F. Basile,et al.  Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells. , 2011, Biochemical pharmacology.

[2]  H. Kurzen,et al.  The cholinergic system in guttate psoriasis with special reference to mast cells , 2011, Experimental dermatology.

[3]  R. Paus,et al.  Activation of transient receptor potential vanilloid-3 inhibits human hair growth. , 2011, The Journal of investigative dermatology.

[4]  Stephen P. H. Alexander,et al.  International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 , 2010, Pharmacological Reviews.

[5]  R. Paus,et al.  Pituitary adenylate cyclase activating polypeptide: an important vascular regulator in human skin in vivo. , 2010, The American journal of pathology.

[6]  L. C. Pôrto,et al.  Cutaneous wound healing of chronically stressed mice is improved through catecholamines blockade , 2010, Experimental dermatology.

[7]  T. George,et al.  Phenotypic heterogeneity, novel diagnostic markers, and target expression profiles in normal and neoplastic human mast cells. , 2010, Best practice & research. Clinical haematology.

[8]  M. Molinari,et al.  The endocannabinoid system: A new entry in remote cell death mechanisms , 2010, Experimental Neurology.

[9]  S. Abraham,et al.  Mast cell-orchestrated immunity to pathogens , 2010, Nature Reviews Immunology.

[10]  Y. Ramot,et al.  Prolactin—a novel neuroendocrine regulator of human keratin expression in situ , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  R. Paus,et al.  Corticotropin-releasing hormone stimulates the in situ generation of mast cells from precursors in the human hair follicle mesenchyme. , 2010, The Journal of investigative dermatology.

[12]  R. Paus,et al.  Methods in hair research: how to objectively distinguish between anagen and catagen in human hair follicle organ culture , 2010, Experimental dermatology.

[13]  A. Miolo,et al.  Effects of palmitoylethanolamide on immunologically induced histamine, PGD2 and TNFalpha release from canine skin mast cells. , 2010, Veterinary immunology and immunopathology.

[14]  M. Maurer,et al.  Innate immunity and allergy in the skin. , 2009, Current opinion in immunology.

[15]  R. Paus,et al.  The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities. , 2009, Trends in pharmacological sciences.

[16]  D. Boger,et al.  Endocannabinoid Modulation of Scratching Response in an Acute Allergenic Model: A New Prospective Neural Therapeutic Target for Pruritus , 2009, Journal of Pharmacology and Experimental Therapeutics.

[17]  Ralf Paus,et al.  The Hair Follicle as a Dynamic Miniorgan , 2009, Current Biology.

[18]  Melissa A Brown,et al.  Mast Cells , 2008, Annals of the New York Academy of Sciences.

[19]  D. Simone,et al.  A Decrease in Anandamide Signaling Contributes to the Maintenance of Cutaneous Mechanical Hyperalgesia in a Model of Bone Cancer Pain , 2008, The Journal of Neuroscience.

[20]  R. Paus,et al.  Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor‐2‐mediated signaling , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  M. Tsai,et al.  Immunomodulatory mast cells: negative, as well as positive, regulators of immunity , 2008, Nature Reviews Immunology.

[22]  D. De Filippis,et al.  Cannabinomimetic Control of Mast Cell Mediator Release: New Perspective in Chronic Inflammation , 2008, Journal of neuroendocrinology.

[23]  D. Piomelli,et al.  The endocannabinoid system in brain reward processes , 2008, British journal of pharmacology.

[24]  R. Palmiter,et al.  Multiple pathways involved in the biosynthesis of anandamide , 2008, Neuropharmacology.

[25]  P. Arck,et al.  Probing the effects of stress mediators on the human hair follicle: substance P holds central position. , 2007, The American journal of pathology.

[26]  R. Paus,et al.  Inhibition of human hair follicle growth by endo‐and exocannabinoids , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  J. Ring,et al.  Adjuvant treatment of atopic eczema: assessment of an emollient containing N‐palmitoylethanolamine (ATOPA study) , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[28]  S. Werner,et al.  Attenuation of Allergic Contact Dermatitis Through the Endocannabinoid System , 2007, Science.

[29]  L. Battistin,et al.  Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL‐2H3 mast cells , 2007, Journal of leukocyte biology.

[30]  M. Maurer,et al.  Mast cells--key effector cells in immune responses. , 2007, Trends in immunology.

[31]  R. Paus,et al.  Towards the development of a simplified long‐term organ culture method for human scalp skin and its appendages under serum‐free conditions , 2007, Experimental dermatology.

[32]  P. Pacher,et al.  The Endocannabinoid System as an Emerging Target of Pharmacotherapy , 2006, Pharmacological Reviews.

[33]  H. Waldmann.  Immunology: Protection and privilege , 2006, Nature.

[34]  P. Arck,et al.  Neuroimmunology of stress: skin takes center stage. , 2006, The Journal of investigative dermatology.

[35]  D. Tiblalexi,et al.  Corticotropin-releasing hormone receptor-1 and histidine decarboxylase expression in chronic urticaria. , 2005, The Journal of investigative dermatology.

[36]  D. Printz,et al.  Detection of differentiation‐ and activation‐linked cell surface antigens on cultured mast cell progenitors , 2005, Allergy.

[37]  Markku Miettinen,et al.  KIT (CD117): A Review on Expression in Normal and Neoplastic Tissues, and Mutations and Their Clinicopathologic Correlation , 2005, Applied immunohistochemistry & molecular morphology : AIMM.

[38]  C. Adra,et al.  Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells. , 2005, The Biochemical journal.

[39]  S. Hunt,et al.  Mast cell deficient and neurokinin-1 receptor knockout mice are protected from stress-induced hair growth inhibition , 2005, Journal of Molecular Medicine.

[40]  J. Rossier,et al.  Constitutive Endocytic Cycle of the CB1 Cannabinoid Receptor* , 2004, Journal of Biological Chemistry.

[41]  G. Marshall.  Internal and External Environmental Influences in Allergic Diseases , 2004, The Journal of the American Osteopathic Association.

[42]  S. Galli,et al.  What is the physiological function of mast cells? , 2003, Experimental dermatology.

[43]  R. Paus,et al.  Kit is expressed by epithelial cells in vivo. , 2003, The Journal of investigative dermatology.

[44]  J. Jester,et al.  Hair follicles serve as local reservoirs of skin mast cell precursors. , 2003, Blood.

[45]  G. Pejler,et al.  Human Mast Cell β-Tryptase Is a Gelatinase 1 , 2003, The Journal of Immunology.

[46]  Alexander J Stokes,et al.  Differential Roles of CB1 and CB2 Cannabinoid Receptors in Mast Cells1 , 2003, The Journal of Immunology.

[47]  Calman Prussin,et al.  IgE, mast cells, basophils, and eosinophils. , 2003, The Journal of allergy and clinical immunology.

[48]  M. Maurer,et al.  Pattern analysis of human cutaneous mast cell populations by total body surface mapping , 2003, The British journal of dermatology.

[49]  B. Cravatt,et al.  Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[50]  C. Fowler,et al.  Effects of the cannabimimetic fatty acid derivatives 2-arachidonoylglycerol, anandamide, palmitoylethanolamide and methanandamide upon IgE-dependent antigen-induced β-hexosaminidase, serotonin and TNFα release from rat RBL-2H3 basophilic leukaemia cells , 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

[51]  D. Lambert,et al.  Receptor-independent effects of natural cannabinoids in rat peritoneal mast cells in vitro. , 2001, Biochimica et biophysica acta.

[52]  J. Kochan,et al.  Human skin-derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes. , 2001, Blood.

[53]  T. Bonner,et al.  Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[54]  R Paus,et al.  The biology of hair follicles. , 1999, The New England journal of medicine.

[55]  M. Herkenham,et al.  Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[56]  A. Buriani,et al.  Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[57]  R. Paus,et al.  Gelatin sponge-supported histoculture of human nasal mucosa , 1995, In Vitro Cellular & Developmental Biology - Animal.

[58]  S. Galli,et al.  Mast cell-dependent amplification of an immunologically nonspecific inflammatory response. Mast cells are required for the full expression of cutaneous acute inflammation induced by phorbol 12-myristate 13-acetate. , 1988, Journal of immunology.

[59]  F. Piscitelli,et al.  Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes. , 2011, Handbook of experimental pharmacology.

[60]  D. Metcalfe,et al.  Mast cell biology: introduction and overview. , 2011, Advances in experimental medicine and biology.

[61]  G. Nilsson,et al.  Mast cell apoptosis and survival. , 2011, Advances in experimental medicine and biology.

[62]  E. Andrews,et al.  The influence of mast cell mediators on migration of SW756 cervical carcinoma cells. , 2008, Journal of pharmacological sciences.

[63]  R. Paus,et al.  A 'hairy' privilege. , 2005, Trends in immunology.

[64]  A. Fleischer,et al.  Itch Associated with Skin Disease , 2003 .

[65]  L. Lichtenstein,et al.  Human mast cells synthesize new granules during recovery from degranulation. In vitro studies with mast cells purified from human lungs. , 1988, Blood.